2017
DOI: 10.1039/c7ra05153k
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 5,5-difluoro-5-phosphono-pent-2-en-1-yl nucleosides as potential antiviral agents

Abstract: A series of hitherto unknown acyclic 5,5-difluoro-5-phosphono-pent-2-en-1-yl-pyrimidines, -purines and -(1,2,4)-triazolo-3-carboxamide were successfully synthesized from (E)-1-bromo-5-diethoxyphosphoryl-5,5-difluoro-pent-2-ene in a stereoselective manner.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Recently, other non-CNAs have been described with important antiviral activity toward the closely related coxsackie B3 virus. , In one of these works, the use of 1,2,3-triazole-based non-natural nucleobases proved to be effective to improve the antiviral activity . However, in other cases, the use of non-natural nucleobases in linear CNAs has not led to significant antiviral activity against coxsackie B4 virus. , Despite all these precedents, at present, there is no approved specific treatment for coxsackie virus infections. The preliminary in vitro antiviral activity of the novel synthesized carbocyclic nucleoside 3d opens the door to carry out additional studies of structure–activity relationships as well as studies of the mode of action.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, other non-CNAs have been described with important antiviral activity toward the closely related coxsackie B3 virus. , In one of these works, the use of 1,2,3-triazole-based non-natural nucleobases proved to be effective to improve the antiviral activity . However, in other cases, the use of non-natural nucleobases in linear CNAs has not led to significant antiviral activity against coxsackie B4 virus. , Despite all these precedents, at present, there is no approved specific treatment for coxsackie virus infections. The preliminary in vitro antiviral activity of the novel synthesized carbocyclic nucleoside 3d opens the door to carry out additional studies of structure–activity relationships as well as studies of the mode of action.…”
Section: Resultsmentioning
confidence: 99%
“… 54 However, in other cases, the use of non-natural nucleobases in linear CNAs has not led to significant antiviral activity against coxsackie B4 virus. 55 , 56 Despite all these precedents, at present, there is no approved specific treatment for coxsackie virus infections. The preliminary in vitro antiviral activity of the novel synthesized carbocyclic nucleoside 3d opens the door to carry out additional studies of structure–activity relationships as well as studies of the mode of action.…”
Section: Resultsmentioning
confidence: 99%